Bio-Synergy Launches DNA Epigenetics Testing Kit in India Targeting Personalized Health
UK health science company Bio-Synergy has launched its DNA Epigenetics Kit in India through partner Kynora Life Sciences, targeting sales of 3-5 million pounds in the first year. The kit analyzes genetic and epigenetic markers, including about 900,000 SNPs and over 300 biological markers, to provide personalized health insights and lifestyle recommendations. Developed in-house, it aims to help consumers understand how lifestyle factors influence gene expression and metabolic health amid rising lifestyle-related disorders in India.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 36/100.
Outlets measured: moneycontrol, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 8 Oct, 12:29 pm. Other outlets followed.
